Exploration the feasibility and additional value of [18F]FDG/[68Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [68Ga]Ga-FAPI-04

被引:1
|
作者
Zheng, Zhe [1 ,2 ,3 ,4 ]
He, Yibo [1 ,2 ,3 ,4 ]
Mao, Wujian [1 ,2 ,3 ,4 ]
Yu, Haojun [1 ,2 ,3 ,4 ]
Wu, Ha [1 ,2 ,3 ,4 ]
Yang, Runjun [1 ,2 ,3 ,4 ]
Gao, Huaping [1 ,2 ,3 ,4 ]
Hu, Pengcheng [1 ,2 ,3 ,4 ]
Shi, Hongcheng [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Nucl Med, Shanghai 200032, Peoples R China
[2] Shanghai Inst Med Imaging, Shanghai 200032, Peoples R China
[3] Fudan Univ, Nucl Med Inst, Shanghai 200032, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Canc Prevent & Treatment Ctr, Shanghai 200032, Peoples R China
关键词
2-[F-18]fluoro-2-deoxy-D-glucose; Fibroblast activation protein inhibitor; Positron emission tomography/Computed tomography; FAPI-weighted PET;
D O I
10.1007/s00259-024-06924-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To validate the feasibility of one-stop 2-[F-18]fluoro-2-deoxy-D-glucose ([F-18]FDG) and [Ga-68]Ga-fibroblast activation protein inhibitor-04 ([Ga-68]Ga-FAPI-04) dual-low-activity-tracer positron emission tomography/computed tomography (PET/CT) at 34 min post-injection of [Ga-68]Ga-FAPI-04 and explore its additional value. Methods: Thirty pairs of patients with suspected malignancies who underwent dual-tracer imaging were enrolled in this retrospective study. The images were reconstructed at 34-39 and 50-60 min after additional injection of [Ga-68]Ga-FAPI-04 (in one-stop FDG-FAPI PET/CT, named PETFDG, PETD34-39, and PETD50-60; in the 2-day protocol, named PETFDG', PETF34-39, and PETF50-60, respectively). Tumour-to-normal ratios (TNR) of lesions in PETFDG, PETD34-39, and PETD50-60 and TNR of lesions in PETF34-39 and PETF50-60 were evaluated separately. To evaluate the potential added value of one-stop FDG-FAPI PET/CT over the 2-day protocol, TNRs of PETFDG, PETD34-39, and PETD50-60 were compared with PETF34-39. The lesion detectability of the two imaging protocols was evaluated by chi-square test. Results: Comparing FAPI-weighted PET (PETD34-39 and PETD50-60) and single-tracer imaging (PETFDG) in one-stop FDG-FAPI PET/CT, TNRs of FAPI-weighted PET were higher than those of PETFDG. PETD34-39 and PETD50-60 showed similar performance in lesion detectability and TNRs (all P > 0.05). In the 2-day protocol, there are no statistically significant differences in TNRs of all lesions at PETF34-39 and PETF50-60. Comparing one-stop FDG-FAPI PET/CT with the 2-day protocol, TNRs of PETF34-39 were significantly higher than those of PETFDG but lower than those of PETD34-39 and PETD50-60. Lesion detectability in the one-stop FDG-FAPI PET/CT was higher than that in the 2-day protocol. The average radiation dose in one-stop FDG-FAPI PET/CT was significantly lower than that in the 2-day protocol (P<0.001). Conclusion: One-stop FDG-FAPI PET/CT at 34 min could provide sufficient information to meet clinical diagnosis and showed better lesion detectability than that in the 2-day protocol.
引用
收藏
页码:638 / 647
页数:10
相关论文
共 50 条
  • [1] Exploration the Feasibility and Additional Value of 18F-FDG/68Ga-FAPI-04 Dual-low-activity-tracer One-stop Total-body PET Imaging after 68Ga-FAPI-04 Injected at 34min
    Zheng, Z.
    He, Y.
    Yang, R.
    Gao, H.
    Hu, P.
    Shi, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S338 - S338
  • [2] Clinical Explorations of [68Ga] Ga-FAPI-04 and [18F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging
    Lin, Yu
    Gao, Huaping
    Zheng, Jiefu
    Al-Ibraheem, Akram
    Hu, Pengcheng
    Shi, Hongcheng
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (06) : 904 - 913
  • [3] Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis
    Yue Zhou
    Xin Yang
    Huipan Liu
    Wenbin Luo
    Hanxiang Liu
    Taiyong Lv
    Junzheng Wang
    Jianhua Qin
    Santao Ou
    Yue Chen
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3493 - 3501
  • [4] Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis
    Zhou, Yue
    Yang, Xin
    Liu, Huipan
    Luo, Wenbin
    Liu, Hanxiang
    Lv, Taiyong
    Wang, Junzheng
    Qin, Jianhua
    Ou, Santao
    Chen, Yue
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) : 3493 - 3501
  • [5] [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in Patients With Primary Liver Malignancies
    Karadogan, S.
    Sanli, Y.
    Erturk, S. M.
    Ibis, A. C.
    Kuyumcu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S41 - S41
  • [6] [68Ga]Ga-FAPI-04 and [18F]FDG PET/ CT in a patient with MDA5 dermatomyositis
    Li, Jia
    Wei, Weijun
    Xu, Wenwen
    Wu, Wanlong
    Liu, Jianjun
    Ye, Shuang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3790 - 3791
  • [7] [68Ga]Ga-FAPI-04 and [18F]FDG PET/ CT in a patient with MDA5 dermatomyositis
    Jia Li
    Weijun Wei
    Wenwen Xu
    Wanlong Wu
    Jianjun Liu
    Shuang Ye
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3790 - 3791
  • [8] Bidirectional dynamic frame prediction network for total-body [68Ga]Ga-PSMA-11 and [68Ga]Ga-FAPI-04 PET images
    Yang, Qianyi
    Li, Wenbo
    Huang, Zhenxing
    Chen, Zixiang
    Zhao, Wenjie
    Gao, Yunlong
    Yang, Xinlan
    Yang, Yongfeng
    Zheng, Hairong
    Liang, Dong
    Liu, Jianjun
    Chen, Ruohua
    Hu, Zhanli
    EJNMMI PHYSICS, 2024, 11 (01):
  • [9] One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study
    Liu, Guobing
    Mao, Wujian
    Yu, Haojun
    Hu, Yan
    Gu, Jianying
    Shi, Hongcheng
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2271 - 2281
  • [10] One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study
    Guobing Liu
    Wujian Mao
    Haojun Yu
    Yan Hu
    Jianying Gu
    Hongcheng Shi
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2271 - 2281